While translating preclinical therapies using animal models can be difficult, a recent Phase 1/2 study (NCT03163511) using human pluripotent stem cell-derived pancreatic endodermal cells showed β-cell maturity could restore insulin levels in T1D patients. This evidence concerns the gene INS and type 1 diabetes mellitus.